University of Montana

ScholarWorks at University of Montana
Biological Sciences Faculty Publications

Biological Sciences

8-2006

Role of the Stable Signal Peptide of Junín Arenavirus Envelope
Glycoprotein in pH-Dependent Membrane Fusion
Joanne York
Jack H. Nunberg
University of Montana - Missoula, jack.nunberg@umontana.edu

Follow this and additional works at: https://scholarworks.umt.edu/biosci_pubs
Part of the Biology Commons

Let us know how access to this document benefits you.
Recommended Citation
York, Joanne and Nunberg, Jack H., "Role of the Stable Signal Peptide of Junín Arenavirus Envelope
Glycoprotein in pH-Dependent Membrane Fusion" (2006). Biological Sciences Faculty Publications. 150.
https://scholarworks.umt.edu/biosci_pubs/150

This Article is brought to you for free and open access by the Biological Sciences at ScholarWorks at University of
Montana. It has been accepted for inclusion in Biological Sciences Faculty Publications by an authorized
administrator of ScholarWorks at University of Montana. For more information, please contact
scholarworks@mso.umt.edu.

JOURNAL OF VIROLOGY, Aug. 2006, p. 7775–7780
0022-538X/06/$08.00⫹0 doi:10.1128/JVI.00642-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Vol. 80, No. 15

Role of the Stable Signal Peptide of Junı́n Arenavirus Envelope
Glycoprotein in pH-Dependent Membrane Fusion
Joanne York and Jack H. Nunberg*
Montana Biotechnology Center, The University of Montana, Missoula, Montana 59812
Received 30 March 2006/Accepted 9 May 2006

The envelope glycoprotein of the arenaviruses (GP-C) is unusual in that the mature complex retains the
cleaved, 58-amino-acid signal peptide. Association of this stable signal peptide (SSP) has been shown to be
essential for intracellular trafficking and proteolytic maturation of the GP-C complex. We identify here a
specific and previously unrecognized role of SSP in pH-dependent membrane fusion. Amino acid substitutions
that alter the positive charge at lysine K33 in SSP affect the ability of GP-C to mediate cell-cell fusion and the
threshold pH at which membrane fusion is triggered. Based on the presumed location of K33 at or near the
luminal domain of SSP, we postulate that SSP interacts with the membrane-proximal or transmembrane
regions of the G2 fusion protein. This unique organization of the GP-C complex may suggest novel strategies
for intervention in arenavirus infection.
serves as a binding receptor for the Old World viruses (10), the
receptor utilized by the major New World group of arenaviruses is unknown (45).
Membrane fusion by GP-C is activated upon acidification of
the maturing endosome (6, 11, 16, 17) and promoted by the
transmembrane G2 subunit. GP-C is a member of the class I
group of viral fusion proteins (27, 52) that include those of the
orthomyxo- and paramyxoviruses, retroviruses, filoviruses, and
coronaviruses. A general view of membrane fusion by these
proteins posits that the native and metastable form of the
envelope glycoprotein complex must be triggered by receptorbinding or acidic pH to undergo a structural reorganization in
which the ectodomain of the transmembrane fusion protein
refolds to form a highly stable six ␣-helical core structure that
brings the viral and cellular membranes into apposition and
thereby facilitates membrane fusion (references 18, 19, 30, and
50 and references therein). Fusion of the arenaviral and endosomal membranes results in deposition of the virion core
into the cell cytoplasm and the initiation of viral replication.
Among the class I viral fusion proteins, the arenavirus GP-C
complex is unique in its retention of the SSP subunit. In addition to serving the conventional role as a cleaved signal peptide, i.e., to direct translocation of the nascent polypeptide to
the endoplasmic reticulum (ER), SSP is also required for intracellular trafficking of the GP-C complex from the ER and
through the Golgi (1, 20), where the G1-G2 precursor is subjected to proteolytic maturation by SKI-1/S1P (9). As in other
class I fusion proteins, this cleavage is essential for the membrane fusion activity of the GP-C complex (32, 34, 53). During
GP-C biogenesis, SSP can be provided in trans to the G1-G2
precursor glycoprotein to reconstitute transport and fusion
activity (1, 20, 53). Myristoylation of SSP is also important for
efficient membrane fusion (53), perhaps due to effects on
GP-C trafficking to specific membrane microdomains (42, 47).
The role of SSP in the structure and function of the tripartite
GP-C complex has not been fully defined.
In the present study, we examine the GP-C complex of the
Junı́n virus, the New World arenavirus responsible for recurring outbreaks of hemorrhagic fever in the pampas grasslands

Arenaviruses are endemic in rodent populations worldwide
(43) and can be transmitted to humans to cause severe acute
hemorrhagic fevers (35, 41). Phylogenetic analysis indicates
that arenavirus species have diversified, along with their rodent
hosts, to form closely related clades of Old World and New
World viruses (13). In Africa, up to 300,000 infections by Lassa
fever virus occur annually (36), and outbreaks of Junı́n, Machupo, and Guanarito viruses arise sporadically in South
America (41). In the United States, transplant-associated infections by Old World lymphocytic choriomeningitis (LCM)
virus have recently been reported (12). In the absence of effective treatment or immunization, the hemorrhagic fever
arenaviruses remain an urgent public health and biodefense
concern.
The arenaviruses are enveloped viruses whose genome consists of two single-stranded RNA molecules that encode ambisense expression of the four viral proteins (8, 14). Because
the envelope glycoprotein (GP-C) mediates entry of the virus
into the host cell and is the primary target for virus-neutralizing antibodies (24, 44), there have been extensive efforts to
understand its structure, function, and immunobiology. The
mature GP-C complex consists of three noncovalently associated subunits: the receptor-binding (G1) and transmembrane
(G2) subunits and a stable signal peptide (SSP) (7, 20, 53) (Fig. 1).
The 58-amino-acid SSP is generated from the GP-C precursor
by the cellular signal peptidase (SPase) and subsequently myristoylated (53). The mature G1 and G2 subunits are produced
upon cleavage of the G1-G2 precursor glycoprotein by the
cellular SKI-1/S1P protease (4, 32, 33) in the early Golgi compartment (9, 15, 23). During virion morphogenesis, GP-C is
transported to the cell surface, where viral budding takes place
(40, 46). GP-C-mediated entry into target cells is initiated by
G1 binding to cell surface receptors, followed by endocytosis of
the virion into smooth vesicles (6). Although ␣-dystroglycan
* Corresponding author. Mailing address: Montana Biotechnology
Center, The University of Montana, Science Complex, Rm. 221, Missoula, MT 59812. Phone: (406) 243-6421. Fax: (406) 243-6425. E-mail:
jack.nunberg@umontana.edu.
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FIG. 1. Schematic representation of the Junı́n virus GP-C glycoprotein and SSP sequences. Amino acids of the Junı́n virus envelope
glycoprotein are numbered from the initiating methionine, and cysteine residues (|) and potential glycosylation sites (Y) are marked. The
SSP and SKI-1/S1P cleavage sites and the resulting SSP, G1, and G2
subunits are indicated. Within G2, the C-terminal transmembrane
(TM) and cytoplasmic (cyto) domains are shown, as are the N- and
C-terminal heptad-repeat regions (light gray shading). A comparison
of SSP sequences among arenavirus species is detailed below. Sequences include the New World isolates Junı́n MC2 (D10072), Tacaribe (M20304), Pichindé (U77601), Machupo (AY129248), and Sabiá
(YP_089665), and Old World isolates Lassa-Nigeria (X52400), Mopeia (M33879), and LCMV-Armstrong (M20869). The N-terminal myristoylation (myr) motif is highlighted in gray, as are charged residues
(E17, K33, K40, and R55) that flank the two hydrophobic (h) regions.

of Argentina. In our genetic analysis of the Junı́n virus SSP, we
identify a charged residue in SSP (lysine 33) that is specifically
required for fusion activity of the GP-C complex. Substitutions
to arginine, histidine, glutamine, and glutamic acid affect the
pH threshold at which cell-cell fusion is triggered. K33 is located in the putative membrane-proximal region of the SSP
ectodomain and may interact with the G2 fusion protein to
regulate membrane fusion.
Results and discussion. Inspection of the amino acid sequences of SSP in the New World and Old World arenaviruses
reveals several well-conserved features (Fig. 1). In addition to
the N-terminal myristoylation site (GX3S/T [53]), the SSPs
contain two extended hydrophobic regions delimited by
charged amino acids (21, 25). Studies in the Old World Lassa
fever virus have indicated that, although either hydrophobic
region is sufficient to target the nascent polypeptide to the ER,
both need be present to enable transport of GP-C to the Golgi
and SKI-1/S1P processing (21). Although several models for
SSP insertion in the membrane have been presented (21, 25),
it is thought that only the N-terminal hydrophobic region spans
the membrane, leaving the C-terminal hydrophobic region as
part of an extended ectodomain (21).
The insertion of transmembrane protein segments can be
influenced by charged residues that flank the hydrophobic regions (3, 29, 39, 49). The N-terminal hydrophobic domain in
the arenavirus SSP is delimited by highly conserved residues
E17 and K33 (Fig. 1). The C-terminal hydrophobic region is
bounded, in the New World arenaviruses, by a positively
charged residue at position 40 (lysine in the Junı́n virus) and by
R55, which is also conserved in the Old World viruses. To
explore the role of these charged residues in SSP on GP-C
structure and function, we mutated each of them individually
to alanine.
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Role of charged residues in SSP. The E17A, K33A, K40A,
and R55A mutations were introduced into a recombinant construct encoding the 58-amino-acid SSP and a termination
codon by using QuikChange mutagenesis (Stratagene) and examined in trans-complementation studies (20) by coexpression
with a recombinant G1-G2 precursor bearing the signal peptide of human CD4 (CD4sp-GPC) (53). GP-C sequences are
from the pathogenic MC2 isolate of Junı́n virus (28, 53). In the
absence of SSP, the G1-G2 precursor expressed by CD4spGPC is retained in the ER and is unavailable for SKI-1/S1P
cleavage in the Golgi; coexpression of SSP in trans is able to
reconstitute the native and fully active GP-C complex (1). This
experimental protocol was used here to obviate concerns regarding potential effects of the mutations on SPase cleavage
per se and to specifically examine the assembly and biological
activities of the GP-C complex.
Vero cells were transfected to express the wild-type and
mutant SSPs in conjunction with the G1-G2 precursor of
CD4sp-GPC. Optimum expression of GP-C is achieved by
using the plasmid T7 promoter and T7 RNA polymerase provided by the recombinant vaccinia virus vTF7-3 (26, 53). Cultures were metabolically labeled, and the GP-C complex was
immunoprecipitated from cell lysates (53) by using the G1directed monoclonal antibody (MAb) BF11 (44). As illustrated
in Fig. 2A, expression of the wild-type SSP in trans recapitulates the pattern of GP-C assembly and maturation observed
using the intact GP-C precursor. In both cases, the mature G1
and G2 subunits are coprecipitated as a heterodisperse (30 to
40 kDa) smear characteristic of these glycoproteins (Fig. 2A,
top panel). These subunits are resolved as the respective 22and 27-kDa polypeptides after deglycosylation by PNGase F
(bottom panel). The unprocessed G1-G2 precursor glycoprotein appears as a major band of 60 kDa (top panel). Upon
expression in trans or from intact GP-C, SSP associates with
the GP-C complex and is coprecipitated by using the anti-G1
MAb BF11 (top panel). In addition to the G1-G2 precursor,
which upon PNGase F-treatment migrates as a 50-kDa
polypeptide, deglycosylation of the intact GP-C also reveals
the GP-C precursor polypeptide bearing the uncleaved SSP, a
finding consistent with incomplete SPase cleavage in transfected cells (22, 25, 53).
Surprisingly, coexpression of the E17A, K33A, K40A, and
R55A mutants of SSP allowed for wild-type biogenesis of the
GP-C complex (Fig. 2A). The mutant SSPs associated with the
GP-C complex (top panel) and promoted SKI-1/S1P processing of the G1-G2 precursor glycoprotein (bottom panel). In
keeping with transit to the Golgi for SKI-1/S1P cleavage, the
mutant GP-C complexes were also transported to the cell surface (Fig. 2B). As determined by flow cytometry using the
anti-G1 MAb BE08 (1, 52), GP-C accumulation on the surface
of intact cells was comparable for all mutant and the wild-type
glycoproteins. Thus, these conserved, charged residues are apparently dispensable for proper membrane insertion of SSP, its
association with the G1-G2 precursor, and its role in enabling
transit of the GP-C complex to the cell surface. The failure of
these nonconservative amino acid changes to perturb GP-C
assembly was unexpected, since charged residues are often
important landmarks for membrane-spanning regions. It is
possible that protein-protein interactions within the nascent
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FIG. 2. Scanning mutagenesis of charged residues in SSP. (A) Wild-type SSP and E17A, K33A, K40A, and R55A mutants were coexpressed
with CD4sp-GPC for trans-complementation studies. Metabolically labeled glycoproteins were immunoprecipitated by using a G1-specific MAb
BF11 (44) and separated on NuPAGE 4 to 12% Bis-Tris gels (Invitrogen) under reducing and denaturing conditions (top panel). In the bottom
panels, the glycoproteins were first treated with PNGase F to resolve the G1 and G2 polypeptides. Expression of the intact GP-C precursor (wt
GP-C) and an SKI-1/S1P cleavage-site-defective mutant (cd GPC) is shown for comparison. Both GP-C and CD4sp-GPC constructs encode an
S-peptide affinity tag (31) appended to the C terminus of the cytoplasmic tail of G2; this tag is innocuous in membrane fusion (52, 53) and irrelevant
to the present experiment. Known GP-C species are labeled at left; minor unidentified bands are also present. The 14C-labeled protein markers
(Amersham Biosciences) are indicated (in kilodaltons). (B) Cell surface expression of GP-C in Vero cells was determined by flow cytometry using
MAb BE08 (44). The cell population was additionally stained by using propidium iodide (1 g/ml) to exclude dead cells. Cells were fixed with 2%
formaldehyde and analyzed by using a FACSCalibur flow cytometer (BD Biosciences). The histograms plot cell number (counts) versus the
fluorescence intensity of MAb binding. Mock-transfected populations and those expressing wild-type (wt) GP-C are shown for comparison.
(C) pH-dependent syncytium formation was detected by using the recombinant vaccinia virus-based ␤-galactosidase-reporter assay (38) as
previously described (52, 53). Cocultures of Vero cells expressing GP-C (and infected with vTF7-3) (26) and those infected with the reporter
vaccinia virus vCB21R-LacZ (2) were pulsed for 30 min in medium adjusted to pH 5.0 and subsequently returned to neutral pH for 5 h to allow
for syncytium formation and LacZ expression. ␤-Galactosidase activity was quantitated by using the chemiluminescent substrate GalactoLite Plus
(Tropix). pH-dependent relative light unit (RLU) measurements are shown after the subtraction of background levels from neutral-pH cultures.
The estimated standard deviation of the difference was calculated (typically 2 to 4%); error bars are not discernible on the scale of the graph.

GP-C precursor may be involved in directing membrane insertion of SSP.
To determine whether the mutations in SSP affected the
ability of GP-C to mediate membrane fusion, we examined
pH-dependent cell-cell fusion by using a ␤-galactosidase fusion
reporter assay (38). Cells coexpressing SSP and CD4sp-GPC
(and T7 RNA polymerase) were cocultured with Vero cell
targets infected with the fusion reporter vaccinia virus
vCB21R-LacZ, expressing the ␤-galactosidase gene under control of the T7 promoter (2). In this assay (52, 53), activation of
GP-C-mediated membrane fusion by acidic pH (5.0) results in
syncytium formation between the effector and reporter cells
and the expression of ␤-galactosidase. As anticipated by their
wild-type biogenesis, GP-C complexes containing the E17A,
K40A, and R55A mutants of SSP were able to support wildtype levels of GP-C-mediated cell-cell fusion (Fig. 2C).
Interestingly, the K33A mutant of SSP was unable to promote membrane fusion by the GP-C complex. Despite proper
biogenesis and assembly, cell-cell fusion was completely abolished by the K33A mutation. This important finding points to
a specific role of SSP in GP-C-mediated membrane fusion.
Role of SSP K33 in promoting membrane fusion. To further
examine the significance of the K33 side chain, we replaced the
lysine with amino acids that differed in size, charge, and hydrogen-bonding potential. The SSP mutants (K33R, K33H,
K33Q, K33E, and K33S) were used in trans-complementation

studies to determine the effect of these parameters on GP-C
biogenesis and cell-cell fusion. In these studies, the metabolically labeled glycoproteins were isolated by using an S-peptide
(Spep) affinity tag appended to the C terminus of G2 (in GP-C)
(52, 53); this was done to reexamine specific aspects of the
previous immunoprecipitation studies. As with the original alanine mutant, none of these changes at position 33 affected the
association of SSP in the GP-C complex (Fig. 3A, top panel) or
SKI-1/S1P cleavage (bottom panel). Furthermore, all of the
mutant GP-C complexes were transported to the cell surface
(Fig. 3B).
Despite wild-type assembly and comparable cell-surface expression among the K33 mutants, the reconstituted GP-C complexes differed markedly in their ability to mediate cell-cell
fusion (Fig. 3C). Replacement of K33 with the positively
charged side chains of arginine or histidine had little effect on
cell-cell fusion. Replacement of the positive charge by the
neutral, polar side chain of glutamine reduced fusogenicity to
20% of wild-type levels, whereas replacement with a negative
charge in glutamic acid decreased cell-cell fusion to 3%. The
residual activity of the K33E mutant was clearly distinct from
the complete absence of cell-cell fusion by the K33A and K33S
mutants (P ⫽ 0.04 and 0.1, respectively).
We infer that maximal membrane fusion activity requires a
positive charge at position 33. Although the nominal pKas of
lysine and arginine may be functionally similar (pH 10.5 and
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FIG. 3. Specific mutagenesis of SSP K33. Amino acid substitutions at K33 of SSP included positively charged residues (R and H), a neutral but
polarized residue (Q), a negatively charged residue (E), and a small polar residue (S), in addition to alanine, a minimally hydrophobic residue. The
SSP mutants were coexpressed in trans-complementation studies. In these experiments, the metabolically labeled glycoproteins were isolated by
using the C-terminal Spep affinity tag and S-Protein-Agarose (Novagen) (52, 53). Image Gauge software (Fuji) was used for quantitative analysis
of isolated proteins. Glycoproteins and deglycosylated polypeptides (A), cell-surface expression of GP-C (B), and pH-dependent cell-cell fusion
(C) are displayed as in Fig. 2. In panel A, note that the background of nonspecifically isolated proteins upon affinity isolation differs from that in
MAb-mediated immunoprecipitation and includes a 19-kDa polypeptide that migrates faster than the deglycosylated G1. Note also that the
distribution of GP-C-expressing cells in panel B varies somewhat from that in Fig. 2B (e.g., K33A) due to differences in transfection and
trans-complementation efficiencies. In panel C, some of the error bars are not discernible on the scale of the graph.

12.5, respectively), the reduction in cell-cell fusion by the histidine mutation is in keeping with its lower pKa (pH 6.0). The
side chain amide nitrogen of glutamine may likewise be providing a partial positive charge. The residual cell-cell fusion
mediated by the charge-reversal mutant K33E is unexpected
based on this model.
To examine whether the charge at position 33 of SSP might
also affect the pH-threshold of GP-C-mediated membrane fusion, we varied the pH of the acidic medium in the cell-cell
fusion reporter assay (Fig. 4). Remarkably, the effects of the

FIG. 4. pH threshold for cell-cell fusion. Cocultures of cells expressing GP-C (and T7 RNA polymerase) and those infected with the
reporter virus vCB21R-LacZ were pulsed for 30 min in medium adjusted to the indicated pH (4.5 through 7.0) by using PIPES and
HEPES buffers (53). All cultures were then returned to neutral pH to
allow for syncytium formation and ␤-galactosidase expression. Raw
relative light unit (RLU) measurements are shown, without subtraction of those at neutral pH (mock). Mock-transfected cells (⫹) and
those expressing CD4sp-GPC in the absence of SSP (⫻) are also
shown. The threshold of cell-cell fusion was calculated as the pH at
which ␤-galactosidase activity was twice the basal level (as determined
by averaging background levels at pH 6.5 and 7.0; threshold ⫽ 7,400
RLU).

SSP mutations on the extent of membrane fusion at pH 5.0
were directly reflected in the pH at which fusion was triggered.
Whereas wild-type SSP supported half-maximal cell-cell fusion
at pH 5.7, the K33H SSP showed half-maximal fusion at pH
5.3. In the wild-type GP-C complex, fusion was maximal at pH
5.5 and decreased toward pH 4.5, presumably due to excessive
protonation. In contrast, cell-cell fusion by the most debilitated
mutants K33Q and K33E continued to increase through pH
4.5. The GP-C complex containing K33S, which did not mediate fusion at pH 5.0, displayed a low level of activity at pH 4.5.
In contrast, control cultures and those expressing the K33Acontaining complex showed only a reduction in background
␤-galactosidase activity at this pH. To further define the pH
threshold at which the respective complexes are initially triggered to undergo membrane fusion, we marked the highest pH
at which ␤-galactosidase activity was twice the background
level. Using this definition, pH thresholds of cell-cell fusion
were determined and are listed in Fig. 4.
This ordering of the threshold pHs (from pH 6.25 in the
wild-type SSP through pH 5.5 for K33Q) makes apparent the
relationship between the extent of positive polarity at SSP
position 33 and the pH at which GP-C-mediated membrane
fusion is initiated. Although the positive charge of lysine would
not itself be altered at low pH, the side chain may interact with
acidic residues that are protonated. Nonionic, hydrogen-bonding interactions within the putative binding pocket may likewise be sensitive to changes in pH. Based on the response to
pH, it is possible that the pocket communicates with the aqueous environment and contains mobile water molecules. In this
context, the charge-reversal mutant K33E might be more compatible with GP-C function than, e.g., alanine, a small hydrophobic residue. Further studies are required to define the
molecular basis underlying the observed structure-activity relationship.
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Nonetheless, these findings provide strong evidence for a
direct role of SSP in GP-C-mediated membrane fusion and
suggest a specific interaction between K33 of SSP and other
components in the GP-C complex. Our previous studies
have shown that SSP requires the cytoplasmic and transmembrane domains of G2 for association (1). Based on the
probable location of K33 at or near (51) the luminal exit of
the membrane-spanning segment of SSP, the interaction
may also involve the membrane-proximal ectodomain of G2.
In this regard, we note that both the immunoprecipitated
(Fig. 2A) and the Spep affinity-isolated (Fig. 3A) GP-C complexes containing the inactive K33A SSP appeared to retain
significantly more complexed G1 and G2 than the wild-type.
Quantitative analysis of phosphorimages from several experiments indicated that the ratio of G1 to affinity-tagged G2 in the
K33A complexes was typically threefold that of the wild-type.
The relative recovery of G1 seemed to be unaffected in the
other SSP mutants. In many viral envelope glycoproteins, dissociation of the receptor-binding subunit from the membraneanchored complex occurs spontaneously and is often facilitated
by receptor binding (37). In the Junı́n virus, the dissociation of
G1 from the GP-C complex is evidenced by the recovery of
shed G1 in cell culture medium (53) and by the reciprocal
ratios of G1 and G2 isolated via the respective subunit (see Fig.
2A versus Fig. 3A). Although the relationship between subunit
shedding and the receptor-induced or low-pH-induced
changes that promote membrane fusion is unclear (48), retention of G1 upon affinity isolation may be taken as a measure of
the stability of the GP-C complex. The enhanced stability of
the K33A SSP complex may thus suggest an explanation for its
inability to mediate pH-dependent cell-cell fusion, namely,
that the alanine mutation excessively stabilizes the native GP-C
complex and prevents the conformational changes induced
upon protonation. The positive charge at K33 may be important in balancing the intrinsic metastability of the native GP-C
complex. In addition, the K33 binding pocket may be directly
involved in responding to pH changes in the maturing endosome. In this model, the arenavirus SSP may act as a clamp to
maintain the native state of the GP-C complex and trigger the
structural reorganization that promotes membrane fusion at
acidic pH.
Implications for antiviral intervention. The unusual tripartite structure of the arenavirus GP-C complex no doubt reflects
the structural and functional requirements for GP-C in the
viral life cycle and thus the potential for novel approaches to
interfere in arenavirus replication and disease. We speculate
that SSP may function to stabilize the native GP-C complex
and modulate the effects of acidic pH on its membrane fusion
activity. Based on the presumed location of position K33, it is
possible that SSP interacts with membrane-proximal or transmembrane regions of the G2 fusion protein. The recent description of a small-molecule inhibitor of New World arenavirus infection that appears to target these same regions of G2
(5) further highlights the importance of these elements of the
GP-C complex in controlling viral entry. Future studies to
define the structure-function relationships that mediate membrane fusion by the unique GP-C complex may provide guidance for the development of effective therapeutic agents to
combat arenavirus infection.
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